NZ born and raised researcher at @MDAndersonNews focused on the molecular basis for B-cell #lymphoma. Opinions are my own.
Houston, TX
Joined March 2015
- Tweets1K
- Following606
- Followers1.2K
- Likes1.6K
Michael Green, PhD retweeted
The AACR special conference on Advances in Malignant Lymphoma showcased the full spectrum of lymphoma research from discovery to clinical impact. Get the highlights on the #AACRBlog: brnw.ch/21x3V83 @GreenLymphoLab @UTMDAnderson #AACRlymphoma26
Michael Green, PhD retweeted
Read “A patient derived xenograft repository capturing clinical and molecular heterogeneity of large B-cell lymphoma,” by #AACRlymphoma26 conference chair Michael Green, as a supplement to today’s plenary session on epigenetics. @GreenLymphoLab aacrjournals.org/bloodcancer…
Thank you to @AACR for continuing to support lymphoma research and provide us with this important forum. #AACRLymphoma26 #lmsm @BCD_AACR
#AACRlymphoma26 chair Michael R. Green adjourned the AACR Conference on Advances in Malignant Lymphoma. We thank the cochairs, invited speakers, and abstract presenters for their contributions to this outstanding program. @GreenLymphoLab
Michael Green, PhD retweeted
Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more:
brnw.ch/21x1Sht
#AACRlymphoma26 @GreenLymphoLab
Michael Green, PhD retweeted
Register by May 11 to get the lowest rates for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the ICML and chaired by Michael R. Green. Learn more:
brnw.ch/21x1o6g
#AACRlymphoma26
Michael Green, PhD retweeted
Deadline Extended:Submit an abstract by April 6 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML).
brnw.ch/21x1bbJ
#AACRlymphoma26 @GreenLymphoLab
Michael Green, PhD retweeted
#AACRlymphoma26 chair Michael R. Green invites you to submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with ICML. Learn more:
brnw.ch/21x15pZ
@GreenLymphoLab
Michael Green, PhD retweeted
Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more:
brnw.ch/21x10Xh
#AACRlymphoma26 @GreenLymphoLab
Michael Green, PhD retweeted
Submit an abstract by March 30 for the AACR Conference on Advances in Malignant Lymphoma (June 24-27; Philadelphia), organized in cooperation with the International Conference on Malignant Lymphoma (ICML). Learn more:
brnw.ch/21x0OLd
#AACRlymphoma26 @GreenLymphoLab
Abstract submissions are open for the AACR/ICML Advances in Malignant Lymphoma meeting!!
June 24-27 in Philadelphia. Please retweet.
aacr.org/meeting/advances-in…
Need PDX models for Lymphoma research? Check out our newest preprint: biorxiv.org/content/10.64898…
We generated and molecularly characterized 48 new models, including 23 from post-CAR T relapse biopsies. All are available to academic researchers through MTA. #lmsm
10 day reviews: Is there any data to show that a 10 day reviewer deadline translates to a 4 day quicker turn-around time for authors? When the 4 day reduction in deadline removes a weekend from the review period it makes it much to spend the necessary time on the paper.
Spatial profiling of diffuse large B-cell lymphoma.
I'm happy to share our latest paper, published today in @NatureGenet - a collaborative effort with @IamLinghua.
nature.com/articles/s41588-0…
Interestingly, lymphomas of immune privileged sites (CNS & testis) have abundant T cells in close contact with tumor B cells that show evidence of activation and cytotixicity, but also hallmarks of exhaustion.
Michael Green, PhD retweeted
Thrilled to share our 1st preprint (!) on @biorxiv “Molecular and cellular dynamics of measurable residual disease (#MRD) progression in myelodysplastic syndromes (MDS).” Led by the indefatigable Yu-Hsiang Chen in the lab (xitter.cf/PhRMAfoundation/status…).
👉👉biorxiv.org/content/10.1101/…
#PhF25 awardee Yu-Hsiang Chen, a postdoc @MDAndersonNews, is using single-cell technology to study #cancer cells that remain after stem cell transplant. Understanding these cells could help develop better treatments. @pbachi
Watch the full interview: phrmafoundation.org/news-eve…
Data sharing for publication: We need a better solution than dbGAP and EGA. They are over-burdened, but waiting 3 months to get an accession number and even longer for data to be released is a curse to research progress. There must be another way.
Save-the-date: AACR/ICML Advances In Malignant Lymphoma, June 24-27, 2026, Philadelphia. Featuring interactive sessions focused on the cutting edge of basic and translational research in Lymphoma. @AACR @icmlugano #lmsm